Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Clinical aspects in atrial fibrillation care Oral Anticoagulation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by